- BreathID Hp
- Events & Webinars
- Patient Information
The BreathID Hp is the most innovative next generation Urea Breath Test (UBT) for diagnosing H. pylori infection and for post-treatment monitoring of H. pylori infection in adults. The clinically-proven accurate test is an easy, single-step procedure for the qualitative detection of urease associated with Helicobacter pylori in the human stomach.
UBTs are well-established and accepted as a reliable, non-invasive method for HP detection, and are recommended and endorsed by numerous medical societies as the test of choice for initial detection as well as for post-treatment monitoring testing. BreathID Hp is the only UBT that delivers immediate results. BreathID Hp is FDA cleared in the U.S. and is CE-approved in Europe for diagnosing and treating Hp. BreathID Hp delivers exceptional sensitivity of 100% and specificity of 99.2% -- accuracy that is unmatched compared to traditional H. pylori tests currently available.
Infection of H. pylori is associated with peptic ulcer disease, gastric adenocarcinoma, and mucosa associated lymphoid tissue (MALT) lymphoma. It is estimated that over 2/3 of the world’s population is infected with the bacteria. The World Health Organization categorizes H. pylori as a group I or definite human carcinogen. Over the course of the last few years, testing for H. pylori in symptomatic patients has become standard practice.